Rauh Simone P, Heymans Martijn W, Mehr David R, Kruse Robin L, Lane Patricia, Kowall Neil W, Volicer Ladislav, van der Steen Jenny T
Department of Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands EMGO Institute for Health and Care Research, VU University Medical Centre, Amsterdam, The Netherlands.
Department of Family and Community Medicine, School of Medicine, University of Missouri, Columbia, Missouri, USA.
BMJ Open. 2016 Aug 30;6(8):e011380. doi: 10.1136/bmjopen-2016-011380.
To evaluate whether a model that was previously developed to predict 14-day mortality for nursing home residents with dementia and lower respiratory tract infection who received antibiotics could be applied to residents who were not treated with antibiotics. Specifically, in this same data set, to update the model using recalibration methods; and subsequently examine the historical, geographical, methodological and spectrum transportability through external validation of the updated model.
1 cohort study was used to develop the prediction model, and 4 cohort studies from 2 countries were used for the external validation of the model.
Nursing homes in the Netherlands and the USA.
157 untreated residents were included in the development of the model; 239 untreated residents were included in the external validation cohorts.
Model performance was evaluated by assessing discrimination: area under the receiver operating characteristic curves; and calibration: Hosmer and Lemeshow goodness-of-fit statistics and calibration graphs. Further, reclassification tables allowed for a comparison of patient classifications between models.
The original prediction model applied to the untreated residents, who were sicker, showed excellent discrimination but poor calibration, underestimating mortality. Adjusting the intercept improved calibration. Recalibrating the slope did not substantially improve the performance of the model. Applying the updated model to the other 4 data sets resulted in acceptable discrimination. Calibration was inadequate only in one data set that differed substantially from the other data sets in case-mix. Adjusting the intercept for this population again improved calibration.
The discriminative performance of the model seems robust for differences between settings. To improve calibration, we recommend adjusting the intercept when applying the model in settings where different mortality rates are expected. An impact study may evaluate the usefulness of the two prediction models for treated and untreated residents and whether it supports decision-making in clinical practice.
评估先前开发的用于预测接受抗生素治疗的痴呆症和下呼吸道感染疗养院居民14天死亡率的模型是否可应用于未接受抗生素治疗的居民。具体而言,在同一数据集中,使用重新校准方法更新模型;随后通过对更新模型的外部验证来检验其历史、地理、方法学和范围的可转移性。
使用1项队列研究来开发预测模型,并使用来自2个国家的4项队列研究对模型进行外部验证。
荷兰和美国的疗养院。
157名未接受治疗的居民被纳入模型开发;239名未接受治疗的居民被纳入外部验证队列。
通过评估辨别力(受试者工作特征曲线下面积)和校准(Hosmer和Lemeshow拟合优度统计量及校准图)来评估模型性能。此外,重新分类表允许对不同模型之间的患者分类进行比较。
应用于病情更严重的未接受治疗居民的原始预测模型显示出良好的辨别力,但校准不佳,低估了死亡率。调整截距改善了校准。重新校准斜率并未显著改善模型性能。将更新后的模型应用于其他4个数据集,辨别力可接受。仅在一个病例组合与其他数据集有显著差异的数据集中校准不足。再次为该人群调整截距改善了校准。
该模型的辨别性能似乎对不同环境之间的差异具有稳健性。为改善校准,我们建议在预期死亡率不同的环境中应用该模型时调整截距。一项影响研究可评估这两个预测模型对接受治疗和未接受治疗居民的有用性,以及它是否支持临床实践中的决策制定。